Ikarian Capital, LLC 13D/13G Filings for NextCure, Inc. (NXTC)

Ikarian Capital, LLC 13D and 13G filings for NextCure, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
5:28 pm
Purchase
2025-12-3113GNEXTCURE INC
NXTC
Ikarian Capital, LLC363,035
9.990%
363,035increase
(New Position)
Filing